Reviva Pharmaceuticals Holdings, Inc.

10-Q Quarter ended 2026-03-31 May 13, 2026 8-K Results of operations (earnings release); Regulation FD disclosure May 13, 2026 8-K Delisting notice or listing-rule failure; Other events May 13, 2026 8-K Regulation FD disclosure; Other events Apr 15, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Mar 30, 2026 10-K Fiscal year ended 2025-12-31 Mar 30, 2026 8-K Entered a material agreement; Regulation FD disclosure Mar 19, 2026 8-K Modified rights of security holders; Amended charter or bylaws; Other events Mar 5, 2026 8-K Delisting notice or listing-rule failure; Other events Jan 23, 2026 8-K Amended charter or bylaws; Shareholder vote results; Regulation FD disclosure; Other events Dec 23, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 13, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Delisting notice or listing-rule failure Oct 17, 2025 8-K Amended charter or bylaws Sep 26, 2025 8-K Entered a material agreement; Regulation FD disclosure Sep 19, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 14, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Entered a material agreement; Regulation FD disclosure Jun 26, 2025 8-K Changed accountants Jun 6, 2025 8-K Regulation FD disclosure; Other events Jun 2, 2025 8-K Entered a material agreement May 30, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Results of operations (earnings release); Regulation FD disclosure May 15, 2025 10-K Fiscal year ended 2024-12-31 Apr 3, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Mar 31, 2025 8-K Director or officer change Feb 18, 2025 8-K Entered a material agreement; Regulation FD disclosure Dec 18, 2024 8-K Regulation FD disclosure; Other events Dec 16, 2024 8-K Amended charter or bylaws; Shareholder vote results Dec 12, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Nov 14, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Regulation FD disclosure; Other events Nov 12, 2024 8-K Director or officer change Sep 17, 2024 8-K/A Entered a material agreement; Regulation FD disclosure Aug 22, 2024 8-K Entered a material agreement; Regulation FD disclosure Aug 21, 2024 10-Q Quarter ended 2024-06-30 Aug 14, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Aug 14, 2024 8-K Regulation FD disclosure; Other events Jul 9, 2024 8-K Entered a material agreement May 29, 2024 8-K Regulation FD disclosure; Other events May 15, 2024